This brand name is authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Ireland, Israel, Malta, Netherlands, New Zealand, Poland, Romania, South Africa, Tunisia, Turkey, UK.
The drug MENOPUR contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
58G97EP42I - FOLLICLE-STIMULATING HORMONE (HUMAN CLONE .LAMBDA.15B .BETA.-SUBUNIT PROTEIN MOIETY REDUCED)
|
|
Urofollitropin contains a highly purified preparation of urinary FSH extracted from the urine of postmenopausal women. FSH stimulates ovarian follicular growth and development as well as gonadal steroid production in women who do not have primary ovarian failure. |
|
2
|
UNII
8XA4VN1LH4 - LUTEINIZING HORMONE
|
|
Lutropin alfa is a recombinant human Luteinising Hormone (r-hLH). Luteinising Hormone (LH) binds on the ovarian theca (and granulosa) cells and testicular Leydig cells, to a receptor shared with human chorionic gonadotropin hormone (hCG). Lutropin alfa in association with a Follicle Stimulating Hormone (FSH) preparation is recommended for the stimulation of follicular development in adult women with severe Luteinising Hormone (LH) and FSH deficiency. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G03GA02 | Human menopausal gonadotrophin | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins |
| G03GA30 | Combinations | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 2036E, 2038G |
| CA | Health Products and Food Branch | 02283093 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 2218-MEE-0616, 28853-05-09 |
| EE | Ravimiamet | 1872895, 1872907, 1872929, 1872930 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 002875, 002892, 087229, 087240 |
| FR | Base de données publique des médicaments | 62538194, 66192829 |
| GB | Medicines & Healthcare Products Regulatory Agency | 193492, 193495, 217077, 48569 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-065191285, HR-H-171568328, HR-H-215920737, HR-H-555823672, HR-H-615646088 |
| IE | Health Products Regulatory Authority | 88396, 88397, 88398, 89055 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 4419, 7023, 7024 |
| MT | Medicines Authority | MA1314/00701, MA1314/00702, MA1314/00703 |
| NL | Z-Index G-Standaard | 16079612 |
| NL | Z-Index G-Standaard, PRK | 128627, 57312 |
| NZ | Medicines and Medical Devices Safety Authority | 12914, 19171, 19172 |
| PL | Rejestru Produktów Leczniczych | 100112368, 100234597, 100234640, 100332220, 100381364 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W53997001, W53997002, W60840001, W60841001, W69055001, W69056001 |
| TN | Direction de la Pharmacie et du Médicament | 5523031 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8697621790018, 8697621790476, 8697621790483, 8697621790612, 8697621790629, 8697621790667, 8697621790704 |
| ZA | Health Products Regulatory Authority | 44/21.10/0382, 44/21.10/0383, A39/21.10/0357 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.